The team’s projects are devoted to the activation/function of CXCR4-ACKR3 (CXCR7) receptors of the CXCL12 chemokines and their receptors, for which she made important breakthroughs regarding the CXCL12/CXCR4/ACKR3 FB’ team has identified the orphan CXCR7/ACKR3 receptor as being the 2nd receptor for CXCL12, which behaves receptors (including CXCR4), and a smaller subgroup of atypical chemokine receptors (including the CXCR7/ACKR3

the non-canonical signaling effectors involved in the activation of Atypical Chemokine Receptor 3 (ACKR3

biased agonism, with the development of approaches to quantify ligand bias and the identification of ACKR3